Patients with a specific gene are more likely to develop long COVID; senators send letters to the Internal Revenue Service, urging them to investigate the practices of nonpartisan hospitals; pregnant workers and workers with newborns could potentially gain job accommodations through a new proposal.
Read More
Certain Fertility Treatments Do Not Increase CVD Risk for Mothers, Study Says
August 9th 2023New research shows that in vitro fertilization with or without intracytoplasmic sperm injection and the use of fresh or frozen embryo transfers were not associated with an increased risk of cardiovascular disease (CVD) for the mother.
Read More
Small Study Shows Utility of ctDNA for Monitoring Treatment Response, Evolution of MDS, AML
August 9th 2023Investigators from China used circulating tumor DNA testing alongside bone marrow assessments to evaluate patients' pretreatment and posttreatment disease levels and to track the course of the disease.
Read More
Dr Kami Maddocks: Advances in DLBCL Treatment Despite Challenges in Research
August 8th 2023Although B-cell lymphomas can be challenging to study, there have been great advances in treatments in the second-line and later, explained Kami Maddocks, MD, professor of Clinical Internal Medicine, the Ohio State James Comprehensive Cancer Center.
Read More
Standard Uptake Value Index May Aid in Diagnosis of Polymyalgia Rheumatica
August 8th 2023Polymyalgia rheumatica (PMR) is an inflammatory disease often misdiagnosed as certain cancers, among other diseases. Researchers have recently made progress to better diagnose PMR using a standard uptake value index based on fluorodeoxyglucose with positron-emission tomography/computed tomography.
Read More
Dr Sara Horst Defines Digital Health and Its Benefits for Clinicians, Patients
August 7th 2023Sara Horst MD, MPH, FACG, discussed how she helps make the electronic medical record more accessible and easier for clinicians to use within her roles as ambulatory director of VUMC Telehealth and Specialty Pharmacy and associate vice chair of Digital Health Operations of the Department of Medicine.
Watch
Gilead Discontinues Phase 3 ENHANCE Trial of Magrolimab/Azacitidine in Higher-Risk MDS
August 7th 2023The phase 3 ENHANCE trial evaluating the first-line combination of magrolimab and azacitidine vs placebo plus azacitidine in patients with higher-risk myelodysplastic syndrome has been discontinued due to futility at a planned analysis.
Read More
What We’re Reading: Heatstroke Calls Surge; Leqembi Update; Childhood Vaccination Rate Misses Target
August 7th 2023A severe heat wave is causing an uptick in heat-related emergency visits; Leqembi set to be rolled out in the coming months; declining childhood vaccination rate raises concerns over winter surge.
Read More
Zilucoplan Demonstrates Consistent Efficacy in Phase 3 RAISE Study of Generalized Myasthenia Gravis
August 5th 2023Nearly half of patients treated with zilucoplan were considered responders on Myasthenia Gravis Activities of Daily Living (MG-ADL) at the first week, suggesting a rapid onset of efficacy.
Read More
Study Finds Neurocutaneous Syndromes Increase Childhood Cancer Risk
August 5th 2023Using data from the Swedish National Medical Birth Register, researchers found that different neurocutaneous syndromes are associated with increased risk of childhood cancer, especially central nervous system tumors.
Read More